CStone Pharmaceuticals (Suzhou) Co., Ltd

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Large Molecule
      • Antibodies

Other Names/Subsidiaries

  • CStone Pharmaceuticals
See more in Biomedtracker

Latest on CStone Pharmaceuticals (Suzhou) Co., Ltd

Scrip

Deal Watch: Novo Nordisk, IMMvention To Partner On Sickle Cell Disease

 
• By Joseph Haas, Dexter Jie Yan, Xu Hu, and Vibha Ravi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novo Nordisk, IMMvention Collaboration

Scrip

AZ China President Under Investigation By Chinese Authorities

 
• By Dexter Jie Yan

Over the past roughly three years, AstraZeneca PLC’s key oncology drugs, including for lung cancer, have been facing gathering clouds in China. Not only are Chinese homegrown rivals nibbling at market

Scrip

Asia Deal Watch: Chugai Extends Relationship With Helsinn

 
• By Joseph Haas, Vibha Ravi, Dexter Jie Yan, Lisa Takagi, and Jung Won Shin

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Helsinn Extends Akynzeo Marketing

Scrip

J&J Continues Atopic Dermatitis Effort With Numab Deal

 
• By Joseph Haas

Johnson & Johnson unveiled its second atopic dermatitis-focused deal this month on 28 May, paying $1.25bn in cash to acquire a subsidiary of Numab Therapeutics AG that houses a Phase II-ready bispe